-
Identification and Management of Pain Medication Abuse and Misuse: Current State and Future Directions
CME Managing chronic pain patients with long-term opioid therapy while minimizing abuse and misuse is still challenging.
Expert Review of Neurotherapeutics, May 1, 2012
-
Current Management of Dermatomyositis
CME Dermatomyositis still has high morbidity and mortality due to lung and other systemic involvement, despite the availability of a large number of therapeutic agents.
International Journal of Clinical Rheumatology, April 3, 2012
-
Prevalence, Clinical Features, and Potential Therapies for Fibromyalgia in Primary Headaches
CME Chronic migraine and tension headache have a high frequency of comorbidity with fibromyalgia, according to a review of prevalence, clinical features, and treatments of these comorbid conditions.
Expert Review of Neurotherapeutics, February 24, 2012
-
Cytotoxics or Biologics in the Treatment of Sjogren’s Syndrome?
CME Several immunosuppressive and cytotoxic agents may be helpful to treat systemic extraglandular features and lymphoma associated with Sjogren's syndrome.
International Journal of Clinical Rheumatology, February 2, 2012
-
Improving Diagnosis of Ankylosing Spondylitis and Spondyloarthritis in General
CME Are physicians diagnosing ankylosing spondylitis too late? The current review says yes and provides tools for clinicians to identify this common condition more expediently.
International Journal of Clinical Rheumatology, November 22, 2011
-
Phototherapy for Sclerosing Skin Conditions
CME Can phototherapy help patients with sclerosing skin disorders? The current review examines this question.
Expert Review of Dermatology, November 14, 2011
-
Rheumatoid Arthritis: Safety of Biologic Therapy
CME How safe are biologic therapies in the treatment of RA? The current review describes the latest evidence on this issue.
Nature Reviews Rheumatology, October 11, 2011
-
Management of Interstitial Lung Disease in Systemic Sclerosis
CME What is the best practice for the identification and management of interstitial lung disease among patients with systemic sclerosis? The current review answers this question.
International Journal of Clinical Rheumatology, September 27, 2011
-
Management of Psoriatic Arthritis From the View of the Dermatologist
CME What is the best practice in the evaluation and management of psoriatic arthritis? The current review addresses these issues.
Nature Reviews Rheumatology, September 13, 2011
-
Clinical Fractures Beyond Low BMD
CME Fracture risk is multifactorial and determined by the material and structural properties of bone as well as by trauma intensity, frequency, and impact.
International Journal of Clinical Rheumatology, August 17, 2011